VIVOPHARM Trademark

Trademark Overview

On Wednesday, May 29, 2013, a trademark application was filed for VIVOPHARM with the United States Patent and Trademark Office. The USPTO has given the VIVOPHARM trademark a serial number of 79133771. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, April 15, 2022. This trademark is owned by VivoPharm Pty Ltd. The VIVOPHARM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in relation to pharmaceuticals; scientific pre-clinical studies, testing and evaluation relating to the efficacy, toxicology and safety including bioanalytical studies of pharmaceutical treatments; scientific and technological services, namely, design of tests, evaluations and studies in relation to the efficacy toxicology and safety including bioanalytic of pharmaceuticals; analysis of statistical data and preparation of reports on the same in the fields of medical and scientific research; provision of scientific research consulting, information and advisory services in relation to the foregoing
vivopharm

General Information

Serial Number79133771
Word MarkVIVOPHARM
Filing DateWednesday, May 29, 2013
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, April 15, 2022
Registration Number4586443
Registration DateTuesday, August 19, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 3, 2014

Trademark Statements

Description of MarkThe mark consists of the wording "VIVOPHARM" with "VIVO" in a thicker font. In the middle of the wording, partially formed by the second letter "V" and the "A", is an oval that is pointing towards the right. The bottom half of the oval is lightly shaded.
Pseudo MarkVIVO PHARM
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in relation to pharmaceuticals; scientific pre-clinical studies, testing and evaluation relating to the efficacy, toxicology and safety including bioanalytical studies of pharmaceutical treatments; scientific and technological services, namely, design of tests, evaluations and studies in relation to the efficacy toxicology and safety including bioanalytic of pharmaceuticals; analysis of statistical data and preparation of reports on the same in the fields of medical and scientific research; provision of scientific research consulting, information and advisory services in relation to the foregoing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 9, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivoPharm Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressBundoora VIC 3083
AU
Party NameVivoPharm Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressAU
Party NameVivoPharm Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressAU

Trademark Events

Event DateEvent Description
Friday, August 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 8, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, August 13, 2013APPLICATION FILING RECEIPT MAILED
Friday, September 13, 2013ASSIGNED TO EXAMINER
Friday, September 13, 2013NON-FINAL ACTION WRITTEN
Saturday, September 14, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 16, 2013REFUSAL PROCESSED BY MPU
Monday, September 16, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 8, 2013REFUSAL PROCESSED BY IB
Tuesday, January 28, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 28, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 13, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 13, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 13, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 18, 2014ASSIGNED TO LIE
Friday, April 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 14, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 14, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 14, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 3, 2014PUBLISHED FOR OPPOSITION
Tuesday, June 3, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 13, 2014NOTIFICATION PROCESSED BY IB
Thursday, June 26, 2014CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, August 19, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, November 19, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, January 28, 2015FINAL DISPOSITION PROCESSED
Wednesday, January 28, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 13, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 16, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 18, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 27, 2017NEW REPRESENTATIVE AT IB RECEIVED
Monday, August 19, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, October 9, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, November 11, 2020TEAS SECTION 71 & 15 RECEIVED
Thursday, January 21, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 13, 2021POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Thursday, December 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 16, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, April 15, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Friday, April 15, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, August 19, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, November 23, 2023INTERNATIONAL REGISTRATION RENEWED
Friday, August 16, 2024TEAS SECTION 71 & 15 RECEIVED

Related Keywords

vivopharm scientific studies relation research toxicology including efficacy safety services pharmaceuticals